Benzinga | May 26, 2021 07:57AM EDT

Evogene Q1 EPS $(0.17) Up From $(0.24) YoY, Sales $333.00K Beat $300.00K Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.17) per share. This is a 29.17 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $333.00 thousand which beat the analyst consensus estimate of $300.00 thousand by 11.00 percent. This is a 344.00 percent increase over sales of $75.00 thousand the same period last year.